Business - Briefly   

Ranbaxy launches Clarithromycin in U.S.

NEW DELHI: Ranbaxy Laboratories on Tuesday launched its approved generic formulation of Clarithromycin immediate release tablets in the U.S. market. The tablets are indicated for the treatment of mild to moderate infections caused by susceptible strains of designated micro-organisms.

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts: Classifieds | Employment | Updates: Breaking News |

Stories in this Section

`Inflation, interest rates need attention'
India may make revised offer under GATS
Maruti Swift makes history
Decline in rupee
Sensex rises further
Bharat Forge pays 125 p.c.
Xerox to buy out Indian arm
HSL pins hopes on revival package
Diamond trading centre in offing
Novartis India declares 200 p.c.
Bullion rates
Exchange rates
IBM signs MoU with TIFR
Ranbaxy launches Clarithromycin in U.S.
Picks up stake in Elder Pharma
SAS partners IIIT-B
Indo Asian expects to double sales
Sub-contract exchange for small units
TMC guidelines modified
Gold Star opens branch

Copyright © 2005, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu